treprostinil dienthanolmine sustained release
2006.219.B
Phase 2 small_molecule completed
Quick answer
treprostinil dienthanolmine sustained release for Critical Limb Ischemia is a Phase 2 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Critical Limb Ischemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed